The estimated Net Worth of Gerald N Herman is at least $4.66 Million dollars as of 16 June 2023. Mr. Herman owns over 14,242 units of Bruker Corp stock worth over $2,333,203 and over the last 6 years he sold BRKR stock worth over $1,074,132. In addition, he makes $1,248,190 as Chief Financial Officer at Bruker Corp.
Sign up
Mr. Herman BRKR stock SEC Form 4 insiders trading
Gerald has made over 1 trades of the Bruker Corp stock since 2023, according to the Form 4 filled with the SEC. Most recently he sold 14,242 units of BRKR stock worth $1,074,132 on 16 June 2023.
The largest trade he's ever made was selling 14,242 units of Bruker Corp stock on 16 June 2023 worth over $1,074,132. On average, Gerald trades about 1,424 units every 0 days since 2018. As of 16 June 2023 he still owns at least 36,462 units of Bruker Corp stock.
You can see the complete history of Mr. Herman stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Gerald Herman biography
Gerald N. Herman serves as Chief Financial Officer of the Company. Mr. Herman has served as our Chief Financial Officer since June 2018, after being named Interim Chief Financial Officer in March 2018. Mr. Herman joined Bruker in 2016 as Vice President and Corporate Controller. Prior to joining Bruker, Mr. Herman had served in senior executive positions with various publicly-traded companies, including as Corporate Vice President—Clinical Operations of PAREXEL International from 2014 to February 2016, and as Corporate Vice President & Controller-Finance of PAREXEL from 2008 to 2013. Prior to 2008, Mr. Herman was Vice President—Corporate Controller of Presstek, Inc. He also served in financial, consulting and accounting roles at various organizations, including as Senior Manager at Arthur Andersen LLP from 1979 to 1987. Mr. Herman is a Certified Public Accountant (CPA) and holds a Master of Business Administration degree from the University of Chicago, and a Master of Science in Taxation from Bentley University.
What is the salary of Gerald Herman?
As the Chief Financial Officer of Bruker Corp, the total compensation of Gerald Herman at Bruker Corp is $1,248,190. There are 3 executives at Bruker Corp getting paid more, with Frank Laukien having the highest compensation of $4,909,640.
How old is Gerald Herman?
Gerald Herman is 62, he's been the Chief Financial Officer of Bruker Corp since 2018. There are 9 older and 10 younger executives at Bruker Corp. The oldest executive at Bruker Corp is Marc Kastner, 74, who is the Independent Director.
What's Gerald Herman's mailing address?
Gerald's mailing address filed with the SEC is C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA, MA, 01821-3915.
Insiders trading at Bruker Corp
Over the last 21 years, insiders at Bruker Corp have traded over $527,877,336 worth of Bruker Corp stock and bought 5,273,190 units worth $50,472,973 . The most active insiders traders include Joerg C Laukien, Isolde Laukien, and Marc M Laukien. On average, Bruker Corp executives and independent directors trade stock every 36 days with the average trade being worth of $16,426,809. The most recent stock trade was executed by Bob Rosenthal on 15 August 2024, trading 12,500 units of BRKR stock currently worth $292,125.
What does Bruker Corp do?
right from the beginning, which is now more than fifty years ago, bruker has been driven by a single idea: to provide the best technological solution for each analytical task. today, worldwide, more than 6,500 employees in over 90 locations on all continents are focusing their efforts on this permanent challenge. bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability. bruker continues to build upon its extensive range of products and solutions, expand its broad base of installed systems and maintain a strong reputation amongst its customers. as one of the world's leading analytical instrumentation companies, bruker remains focused on developing state-of-the-art technologies and innovative solutions for today’s ever complex analytical questions. bruker - innovation with integrity. bruker corporation company pages bruker axs: https://www
What does Bruker Corp's logo look like?
Complete history of Mr. Herman stock trades at Bruker Corp
Bruker Corp executives and stock owners
Bruker Corp executives and other stock owners filed with the SEC include:
-
Frank Laukien,
Chairman of the Board, President, Chief Executive Officer -
Mark Munch,
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division -
Juergen Srega,
President of Bruker CALID Group and Bruker Daltonics Division -
Gerald Herman,
Chief Financial Officer -
Dr. Frank H. Laukien Ph.D.,
Chairman, CEO & Pres -
Burkhard Prause,
President and Chief Executive Officer, Bruker Energy & Supercon Technologies, Inc -
Falko Busse,
President, Bruker BioSpin Group -
Dr. Mark R. Munch Ph.D.,
Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division -
Juergen Srega,
Pres of Bruker CALID Group & Bruker Daltonics Division -
Gerald N. Herman,
Exec. VP, CFO, Corp. Controller & Interim Head of IR -
Dr. Falko Busse Ph.D.,
Pres of Bruker BioSpin Group -
John Ornell,
Independent Director -
Richard Packer,
Independent Director -
Robert Rosenthal,
Independent Director -
Adelene Perkins,
Independent Director -
William Linton,
Lead Independent Director -
Marc Kastner,
Independent Director -
Hermann Requardt,
Independent Director -
Cynthia Friend,
Independent Director -
Miroslava Minkova,
Director, Investor Relations & Corporate Development -
Bonnie Anderson,
Independent Director -
J. Brent Alldredge J.D.,
Gen. Counsel -
Justin Joseph Ward,
Sr. Director of Investor Relations & Corp. Devel. -
Kristin S. Caplice,
Sec. -
Dr. Burkhard Prause,
Pres and CEO of Bruker Energy & Supercon Technologies, Inc. -
Urban Faeh,
Pres of Bruker Optics Division & Managing Director of Bruker Optik GmbH -
Stacey Desrochers,
Treasurer & Director of Investor Relations -
Collin J. D'Silva,
Pres of Chemical Analysis Division -
M Christopher Canavan,
Director -
Richard Kniss,
Director -
Ingen Chris Van,
Director -
Stephen W. Fesik,
Director -
Rene Lenggenhager,
President, BioSpin Group -
Anthony L Mattacchione,
Sr VP, Corp Fin & Accounting -
Gilles Gerard Jean Martin,
Director -
Joerg C Laukien,
10% owner -
Michael Gunnar Knell,
Chief Accounting Officer -
Brenda J Furlong,
Director -
Wolf Dieter Emmerich,
Director -
Taylor Crouch,
Director -
Bob Rosenthal,
-
Laura Francis,
Chief Financial Officer -
John Hulburt,
Dir. of Audit /SEC Compliance -
Martin Haase,
Senior Vice President -
Thomas Werner Bachmann,
President Bruker BioSpin Group -
Charles F Jr Wagner,
Director -
Bernhard Wangler,
Director -
Bernd Gewiese,
President, Bruker BioSpin Corp -
Werner Maas,
President, Bruker BioSpin Corp -
Tony Werner Keller,
Director -
Brian P Monahan,
Corporate Controller -
Dirk D Laukien,
10% owner -
Marc M Laukien,
10% owner -
William J Knight,
Chief Financial Officer -
Richard M Stein,
Secretary -
Isolde Laukien,
10% owner -
Collin J Dsilva,
Director -
Philip Ma,